Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 5/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1961403 | 0.95 | POLB (0.46) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL29878165 | 0.93 | POLB (0.45) | LMNAPOLBALDH1A1HPGDKMT2A | |
| SCHEMBL28474394 | 0.91 | GAA (0.43) | LMNAPOLBALDH1A1KMT2ARAB9A | |
| SCHEMBL22169204 | 0.87 | LMNA (0.46) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL9245030 | 0.83 | LMNA (0.57) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL22480306 | 0.82 | LMNA (0.45) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL11535456 | 0.82 | ALDH1A1 (0.51) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL22169130 | 0.82 | LMNA (0.42) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL2125917 | 0.81 | LMNA (0.50) | LMNAPOLBALDH1A1HPGDHTT | |
| SCHEMBL15058806 | 0.81 | LMNA (0.50) | LMNAPOLBALDH1A1HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097438-A1 | ORGANIC POSITIVE ELECTRODE, AND DOUBLE-ION BATTERY AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳先进技术研究院 | 2025-05-15 | — | — | WO | claimed |
| CN-115304564-A | Preparation method of S-tetrahydrofuran formic acid | 成都融创亿恒生物医药科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-112851623-B | Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof | 中国科学院兰州化学物理研究所 | 2022-04-08 | — | — | CN | claimed |
| EP-2701164-B1 | Electromagnet device | OMRON TATEISI ELECTRONICS CO (JP) | 2018-09-12 | — | — | EP | claimed |
| CN-206299895-U | Counting, energy-saving high-vacuum electromagnetic valve | 上海巨良电磁阀制造有限公司 | 2017-07-04 | — | — | CN | claimed |
| CN-106594385-A | Energy-saving high-vacuum electromagnetic valve with counting function | 上海巨良电磁阀制造有限公司 | 2017-04-26 | — | — | CN | claimed |
| CN-105646634-A | Preparation method of impurities of obeticholic acid | 中国药科大学 | 2016-06-08 | — | — | CN | claimed |
| EP-2701164-A2 | Electromagnet device | Omron Corporation (JP) | 2014-02-26 | — | — | EP | claimed |
| US-12551490-B2 | Heterocyclic modulators of lipid synthesis | SAGIMET BIOSCIENCES INC. (US) | 2026-02-17 | — | — | US | disclosed |
| WO-2025097438-A1 | ORGANIC POSITIVE ELECTRODE, AND DOUBLE-ION BATTERY AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳先进技术研究院 | 2025-05-15 | — | — | WO | disclosed |
| CN-119768473-A | Polymer composition and single layer phase difference material | 日产化学株式会社 | 2025-04-04 | — | — | CN | disclosed |
| US-20240400552-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | SAGIMET BIOSCIENCES INC. | 2024-12-05 | — | — | US | disclosed |
| CN-117327284-B | Preparation method of sulfur-containing onium ion organic silicon resin with marine antifouling function | 山东海曦新材料有限公司 | 2024-02-27 | — | — | CN | disclosed |
| WO-2024038887-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2024-02-22 | — | — | WO | disclosed |
| EP-0827406-A4 | — | — | 1998-03-11 | — | — | EP | disclosed |
| WO-1996027379-A9 | CARBOPEPTOIDS AND CARBONUCLEOTOIDS | — | 1996-11-28 | — | — | WO | disclosed |
| WO-1996027379-A1 | CARBOPEPTOIDS AND CARBONUCLEOTOIDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-09-12 | — | — | WO | disclosed |
| US-5461175-A | Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method | FISCHER LUTZ (DE) | 1995-10-24 | — | — | US | disclosed |
| EP-0632794-A1 | METHOD FOR SEPARATING ENANTIOMERS OF ARYLOXIPROPANOLAMINE DERIVATIVES, AND CHIRAL SOLID-PHASE CHROMATOGRAPHY MATERIAL FOR USE IN THE METHOD | FISCHER, Lutz (DE) | 1995-01-11 | — | — | EP | disclosed |
| WO-1993009075-A1 | METHOD FOR SEPARATING ENANTIOMERS OF ARYLOXIPROPANOLAMINE DERIVATIVES, AND CHIRAL SOLID-PHASE CHROMATOGRAPHY MATERIAL FOR USE IN THE METHOD | FISCHER LUTZ (DE) | 1993-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400552-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | FASN, FADS1, FADS2 | LMNA 3576/4885POLB 2667/4885ALDH1A1 651/4885 |
| US-12551490-B2 | Heterocyclic modulators of lipid synthesis | FASN, FADS1, FADS2 | LMNA 2876/4885POLB 3427/4885ALDH1A1 540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.